LibraryBy pinki shah / May 14, 2022 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS Clear Displaying 1,051 - 1,075 of 2,573 « 1 … 41 42 43 44 45 … 103 » Role of Interleukins in TIME to Improve Immunotherapy Efficacy By: Suresh Ramalingam, MD View Video Upfront Treatment for Common Ovarian Cancer (High Grade Serous) Versus Rare Histologies-- Focus on PARPi and Other Targeted Therapies By: Tara Castellano, MD View PDF Immunotherapy Updates in Melanoma By: Thach-Giao Truong, MD View PDF Immunotherapy in Gynecologic Malignancies By: Thomas Herzog, MD View PDF Immunotherapy in Gynecologic Malignancies By: Thomas Herzog, MD View Video Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies By: Thomas Herzog, MD View PDF Immunotherapy and Other Systemic Therapy in Gynecologic Malignancies By: Thomas Herzog, MD View Video What Comes After Immunotherapy Failure in Terms of More Immunomodulation (Anti-Angiogenic Agents, IL-15, OX-40 and Others)? By: Ticiana Leal, MD View PDF What Comes After Immunotherapy Failure in Terms of More Immunomodulation (Anti-Angiogenic Agents, IL-15, OX-40 and Others)? By: Ticiana Leal, MD View Video Outside the box applications of Cryoablation By: Afshin Gangi, MD View PDF Navigation systems becoming mainstream By: Afshin Gangi, MD View PDF IRE in prostate cancer By: Ahmed Eldefrawy, MD View PDF “Block” the pain during liver ablation By: Alan Alper Sag, MD View PDF Role of Nerve monitoring in Cryoablation By: Alan Alper Sag, MD View PDF 3rd Annual James G. Caridi Lecture By: Alda Tam, MD View PDF CT-guided Interventions: Reduction of Needle Tip Beam Hardening Artifact with Low Atomic Number Materials in a Phantom and Porcine Model By: Allison Couillard, MD View PDF Tip Artifact During CT-Guided Interventions: Artifact Reduction Using a Gantry Tilt Method, Phantom and Animal Model Results By: Allison Couillard, MD View PDF Microwave Ablation of Oligometastatic Tumors in the Retroperitoneum By: Allison Couillard, MD View PDF Renal Bleeding Events with Histotripsy vs. Cryoablation in a Porcine Survival Model By: Allison Couillard, MD View PDF Three-Dimensional Rotational Angiography (3DRA) Assisted Cone Beam Computed Tomography (CBCT) Guided Microwave Ablation (MWA) in the Treatment of Hepatic Malignancy By: Benjamin Daniel, MD View PDF Blocks in Pain Management – How I Do It By: Blake Jacks, MD View PDF RF Ablation and Cementoplasty in Spine By: Brian Schiro, MD View PDF Feasibility of MW Ablation in Pancreas By: Chiara Floridi, MD View PDF IRE and Desmoid tumors, early experience By: Chris Sinsabaugh, MD View PDF Adrenal Ablation By: Constantino Pena, MD View PDF
